INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
19,130,683
Share change
-230,053
Total reported value
$141,563,460
Price per share
$7.40
Number of holders
58
Value change
-$10,368,061
Number of buys
32
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q1 2016

As of 31 Mar 2016, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,130,683 shares. The largest 10 holders included Devon Park Associates, LLC, RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, Point72 Asset Management, L.P., BLACKROCK ADVISORS LLC, SENZAR ASSET MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and EverPoint Asset Management, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.